SANGART Trademark

Trademark Overview

On Wednesday, April 24, 2002, a trademark application was filed for SANGART with the United States Patent and Trademark Office. The USPTO has given the SANGART trademark a serial number of 76400811. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 13, 2017. This trademark is owned by Sangart, Inc.. The SANGART trademark is filed in the Pharmaceutical Products category with the following description:

hemoglobin based oxygen carriers, namely blood substitute for human use
sangart

General Information

Serial Number76400811
Word MarkSANGART
Filing DateWednesday, April 24, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 13, 2017
Registration Number3101082
Registration DateTuesday, June 6, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 28, 2003

Trademark Statements

Goods and Serviceshemoglobin based oxygen carriers, namely blood substitute for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 13, 2017
Primary Code005
First Use Anywhere DateFriday, February 10, 2006
First Use In Commerce DateFriday, February 10, 2006

Trademark Owner History

Party NameSangart, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameSangart, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameSangart, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Friday, January 13, 2017CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, June 6, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Saturday, April 14, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, April 13, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, April 13, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, March 21, 2012TEAS SECTION 8 & 15 RECEIVED
Tuesday, June 6, 2006REGISTERED-PRINCIPAL REGISTER
Monday, April 24, 2006LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, April 14, 2006ASSIGNED TO LIE
Friday, April 7, 2006ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 24, 2006STATEMENT OF USE PROCESSING COMPLETE
Wednesday, March 8, 2006USE AMENDMENT FILED
Wednesday, March 8, 2006TEAS STATEMENT OF USE RECEIVED
Wednesday, November 2, 2005EXTENSION 5 GRANTED
Thursday, October 20, 2005EXTENSION 5 FILED
Thursday, October 20, 2005TEAS EXTENSION RECEIVED
Tuesday, July 26, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 5, 2005EXTENSION 4 GRANTED
Friday, April 15, 2005EXTENSION 4 FILED
Friday, April 15, 2005TEAS EXTENSION RECEIVED
Thursday, January 13, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 29, 2004EXTENSION 3 GRANTED
Wednesday, October 20, 2004EXTENSION 3 FILED
Wednesday, October 20, 2004TEAS EXTENSION RECEIVED
Friday, April 30, 2004EXTENSION 2 GRANTED
Wednesday, April 21, 2004EXTENSION 2 FILED
Wednesday, April 28, 2004CASE FILE IN TICRS
Wednesday, April 21, 2004TEAS EXTENSION RECEIVED
Thursday, October 23, 2003EXTENSION 1 GRANTED
Friday, October 10, 2003EXTENSION 1 FILED
Friday, October 10, 2003TEAS EXTENSION RECEIVED
Tuesday, April 22, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 28, 2003PUBLISHED FOR OPPOSITION
Wednesday, January 8, 2003NOTICE OF PUBLICATION
Thursday, November 21, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 28, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2002PAPER RECEIVED
Thursday, September 19, 2002NON-FINAL ACTION MAILED
Wednesday, August 21, 2002ASSIGNED TO EXAMINER

Related Keywords

sangart blood substitute human namely carriers based oxygen hemoglobin